MS-Selfie

MS-Selfie

Home
Notes
MS-Selfie Research
MS-Selfie Microsite
Contact
Q&A
Archive
Leaderboard
About
How to avoid a DMT cul-de-sac?
You should try to push back from being labelled as having SPMS or PPMS to prevent limiting your treatment options.
 • 
Gavin Giovannoni
20
Q&A 99: treatment sequencing
An anti-CD20 therapy or cladribine? Or should I wait for tolebrutinib to become available?
 • 
Gavin Giovannoni
51
Q&A 98: male sexual dysfunction in MS
Sexual dysfunction is a common symptom in men with MS, with a prevalence that surpasses that seen in the general population and other chronic disease…
 • 
Gavin Giovannoni
4

June 2025

Gamechangers
I predict that cheap generic oral cladribine, fenebrutinib, prophylactic EBV vaccines and antiviral treatments for acute EBV-associated infectious…
 • 
Gavin Giovannoni
53
O Canada
When you get away from the toads, you have time to test new ideas and revisit old ideas and concepts with a critical audience.
 • 
Gavin Giovannoni
28
16:51
Q&A 97: Chemobrain?
The chemotherapy you had for your ovarian cancer (cisplatin and taxol) are neurotoxic and are likely to have contributed to your worsening function.
 • 
Gavin Giovannoni
16
Q&A 96: skin rejuvenation therapy and MS
Is it safe for someone with MS to have polynucleotide skin injections and radio frequency, ultrasound and micro-needling therapy for skin rejuvenation?
 • 
Gavin Giovannoni
10
Q&A 95: I live in Scotland should I have AHSCT done privately?
Almost all the cases of MS treated with AHSCT in the UK as being performed in London and Sheffield, the epicentres of AHSCT MS treatment.
 • 
Gavin Giovannoni
23
Q&A 94: rebound on switching from fingolimod to cladribine
I don’t think cladribine has failed you. Sadly, your relapse occurred in a window before cladribine had a chance to work. This was preventable.
 • 
Gavin Giovannoni
16
Type 1 diabetes prevention: lessons for MS
As a thought experiment would you trade in MS for having T1DM or would you stick with the autoimmune disease you know already?
 • 
Gavin Giovannoni
25
An NHS in crisis
The UK public requires a new deal with the NHS, becoming a safety net and not necessarily the sole healthcare provider for its citizens.
 • 
Gavin Giovannoni
40
Infectious mononucleosis - a pragmatic target for preventing multiple sclerosis
EBV vaccines & antiviral treatment of IM
 • 
Gavin Giovannoni
19
© 2025 Gavin Giovannoni
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture